Redcare Pharmacy N.V.
RDC.DEHealthcareLEI 529900JK6UXHY1YKZ082
At a glance
- Most recent filing on June 12, 2024 — a trade by Köhler E. on Jun 7, 2024.
- Over the past 90 days: 0 open-market buys.
- This page shows 25 visible filings, of which 19 open-market buys, going back to December 15, 2017.
This buy came out above 57% of all scored insider buys of the past twelve months. A rank, not a forecast.
How the company itself measures up
Four components from the annual figures and the price series, compared with the other companies on the same date. Separate from the filing above, and separate from the question of whether this is a good moment.
On this measurement the company came out above 36% of the companies measured. That says something about the company's numbers, not about its share price.
As of Jul 31, 2026 · methodology 0.4.0
| Component | What is measured | Sub-score | Weight | Compared with |
|---|---|---|---|---|
| Quality | gross profit relative to total assets | 40% | all measured companies | |
| Valuation | operating profit relative to the value of the whole business | 34% | all measured companies | |
| Momentum | price return over twelve months, excluding the most recent month | 25% | all measured companies | |
| What goes to shareholders | dividends and share buybacks relative to market value | — | not measured — reweighted |
Labels on this measurement: Stretched balance sheet. These are notes about the data. Nothing is subtracted from the score, and it is not a warning about the company.
These figures only mean something in comparison: they take on meaning next to the other companies of that same date. See the full ranking →
Price history and buy moments
- 19 marked buys — most recent:
- Mar 5, 2021 · price 179.8
- Mar 5, 2021 · price 179.8
- May 10, 2021 · price 153.6
- May 10, 2021 · price 153.6
- May 11, 2021 · price 152.3
- May 11, 2021 · price 152.3
Every visible filing
What was filed, most recent first. On an award the register reports a price of 0 — nothing was paid — and then the Quantity column tells you how large the filing was.
| Reported | Filed by | Role | Category | Quantity | Amount |
|---|---|---|---|---|---|
| Jun 12, 2024 | Köhler E. | Vice Chairman of the Supervisory Board | Open-market buy | 420 | €20,975 |
| May 16, 2022 | Köhler J. | Supervisory Board Member | Open-market buy | 250 | €18,965 |
| May 16, 2022 | Köhler A. | Supervisory Board Member | Open-market buy | 250 | €19,000 |
| May 10, 2022 | Köhler J. | supervisory board member | Open-market buy | 1,000 | €88,500 |
| May 10, 2022 | Köhler A. | supervisory board member | Open-market buy | 1,000 | €88,500 |
| Sep 6, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 400 | €60,680 |
| Sep 6, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 300 | €45,330 |
| Sep 3, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 300 | €44,760 |
| Sep 2, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 500 | €74,150 |
| Sep 2, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 600 | €88,920 |
| Sep 2, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 100 | €14,810 |
| Sep 2, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market buy | 300 | €44,370 |
| Aug 13, 2021 | Fastre L. | Chief Sales Officer, BE/NL/FR/CH | Open-market buy | 99,330 | €12,813,570 |
| May 26, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Option exercise | 10,000 | nothing paid |
| May 26, 2021 | Sünderhauf R. | Managing Director nu3 GmbH | Open-market sell | 10,000 | €1,572,000 |
| May 14, 2021 | Fastre L. | Chief Sales Officer, BE/NL/FR/CH | Open-market buy | 670 | €99,830 |
| May 14, 2021 | Fastre L. | Chief Sales Officer, BE/NL/FR/CH | Open-market buy | 680 | €99,960 |
| May 13, 2021 | Fastre L. | Chief Sales Officer, BE/NL/FR/CH | Open-market buy | 650 | €99,450 |
| May 13, 2021 | Fastre L. | Chief Sales Officer, BE/NL/FR/CH | Open-market buy | 650 | €98,800 |
| Mar 10, 2021 | Brüse D. | Chief Brand Officer | Open-market buy | 1,390 | €261,320 |
| Mar 10, 2021 | Brüse D. | Chief Brand Officer | Open-market buy | 160 | €30,016 |
| Dec 15, 2017 | Weber St. | — | Open-market sell | 70,000 | nothing paid |
| Dec 15, 2017 | Söder B. | — | Open-market sell | 6,000 | nothing paid |
| Dec 15, 2017 | Pyttel J.C. | — | Open-market sell | 150,000 | nothing paid |
| Dec 15, 2017 | Fischer M.M. | — | Open-market sell | 70,000 | nothing paid |
Follow this company
Loading follow status…
The insider, quant and timing scores stand apart from one another and are meant as context. There is no threshold in them (“above such and such is worth buying”), we do not add them up into a single figure, and none of it is a recommendation. How they are calculated is in the methodology.